Inventor · disambiguated record
Susanta Samajdar
Also filed as: SAMAJDAR SUSANTA
31 granted patents·24 pending applications·117 citations·filing 2011–2025
96Inventor score
Files withAURIGENE DISCOVERY TECH LTD20AURIGENE ONCOLOGY LTD12MITOBRIDGE INC8EISAI R&D MAN CO LTD5ORION CORP4
Top patents by PatentIndex Score
55 records- 0197US10995100B2Bicyclic heterocyclyl derivatives as IRAK4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Granted May 4, 2021·6 cites·3 claims
- 0296US9732095B2Bicyclic heterocyclyl derivatives as IRAK4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2015·Granted Aug 15, 2017·23 cites·135 claims
- 0395US11691987B2Bicyclic heterocyclyl derivatives as IRAK4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2021·Granted Jul 4, 2023·3 cites·22 claims
- 0494US11981685B2Bicyclic heterocyclyl derivatives as IRAK4 inhibitorsAURIGENE ONCOLOGY LTD·Filed 2023·Granted May 14, 2024·1 cites·5 claims
- 0594US11865114B2Method for treating diseases using SMARCA2/4 degradersAURIGENE DISCOVERY TECH LTD·Filed 2020·Granted Jan 9, 2024·5 cites·46 claims
- 0694US10399958B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2016·Granted Sep 3, 2019·7 cites·20 claims
- 0793US10047104B2Bicyclic heterocyclyl derivatives as IRAK4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2017·Granted Aug 14, 2018·11 cites·135 claims
- 0892US11174232B2Substituted heterocyclyl derivatives as CDK inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Granted Nov 16, 2021·3 cites·14 claims
- 0991US10479775B1PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2019·Granted Nov 19, 2019·7 cites·20 claims
- 1091US10160753B2Indazole compounds as IRAK4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2015·Granted Dec 25, 2018·14 cites·129 claims
- 1190US10640517B2Bicyclic heterocyclyl derivatives as IRAK4 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2018·Granted May 5, 2020·6 cites·135 claims
- 1289US12410193B2Bicyclic heterocyclyl derivatives as IRAK4 inhibitorsAURIGENE ONCOLOGY LTD·Filed 2024·Granted Sep 9, 2025·0 cites·9 claims
- 1389US2025361244A1Bicyclic heterocyclyl derivatives as irak4 inhibitorsAURIGENE ONCOLOGY LTD·Filed 2025·Application pending·0 cites
- 1488US10689347B2Substituted heterocyclyl derivatives as CDK inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Granted Jun 23, 2020·4 cites·30 claims
- 1587US11578052B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2021·Granted Feb 14, 2023·1 cites·16 claims
- 1687US10336697B2Spiro[cyclobutane-1,3′-indolin]-2′-one derivatives as bromodomain inhibitorsORION CORP·Filed 2016·Granted Jul 2, 2019·6 cites·30 claims
- 1785US9796683B2Tetrasubstituted alkene compounds and their useEISAI R&D MAN CO LTD·Filed 2016·Granted Oct 24, 2017·6 cites·32 claims
- 1884US10906885B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2019·Granted Feb 2, 2021·1 cites·18 claims
- 1984US2024417383A1Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2024·Application pending·0 cites
- 2082US2023373948A1Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2023·Application pending·0 cites
- 2180US11419875B2Compounds and compositions for treating hematological disordersAURIGENE DISCOVERY TECH LTD·Filed 2018·Granted Aug 23, 2022·5 cites·51 claims
- 2276US2024156814A1Method for Treating Diseases Using SMARCA2/4 DegradersAURIGENE ONCOLOGY LTD·Filed 2024·Application pending·0 cites
- 2375US11186576B2Pyrazolo[1,5-A][1,3,5]triazine and pyrazolo[1,5-A]pyrimidine derivatives as CDK inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2016·Granted Nov 30, 2021·1 cites·22 claims
- 2475US9227969B2Compounds and compositions as inhibitors of MEKBOCK MARK GARY·Filed 2014·Granted Jan 5, 2016·2 cites·16 claims
- 2574US12428379B2Acylsulfonamide KAT6A inhibitorsOLEMA PHARMACEUTICALS INC·Filed 2024·Granted Sep 30, 2025·0 cites·27 claims
- 2674US10077259B2Bicyclic heterocyclic derivatives as bromodomain inhibitorsORION CORP·Filed 2015·Granted Sep 18, 2018·2 cites·11 claims
- 2774US9067920B2Compounds useful for inhibiting Chk1JOSEPH SAJAN·Filed 2011·Granted Jun 30, 2015·3 cites·10 claims
- 2871US2024270734A1Pyridazine Derivatives as SMARCA2/4 DegradersAURIGENE ONCOLOGY LTD·Filed 2024·Application pending·0 cites
- 2970US12331023B2Substituted heterocyclyl derivatives as CDK inhibitorsAURIGENE ONCOLOGY LTD·Filed 2021·Granted Jun 17, 2025·0 cites·95 claims
- 3064US2022281871A1Pyrazolo[1,5-A][1,3,5]Triazine and Pyrazolo[1,5-A]Pyrimidine Derivatives as CDK InhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2021·Application pending·0 cites
- 3160US2022339161A1Compounds and compositions for treating hematological disordersAURIGENE DISCOVERY TECH LTD·Filed 2022·Application pending·0 cites
- 3259US12371426B2Pyridazine derivatives as SMARCA2/4 degradersAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Jul 29, 2025·0 cites·118 claims
- 3358US2025092066A1Substituted bicyclic heterocycles as malt-1 inhibitorsAURIGENE ONCOLOGY LTD·Filed 2023·Application pending·0 cites
- 3457US2025059204A1Fused benzoisoxazolyl compounds as kat6a inhibitorsAURIGENE ONCOLOGY LTD·Filed 2022·Application pending·0 cites
- 3557US2025163049A1Fused bicyclic heterocyclyl compounds as usp1 inhibitorsEXELIXIS INC·Filed 2023·Application pending·0 cites
- 3655US2024132475A1Substituted pyrazolyl compounds as malt-1 inhibitorsAURIGENE ONCOLOGY LTD·Filed 2022·Application pending·0 cites
- 3754US2025145609A13-substituted pyridazine compounds as smarca2 and/or smarca4 degradersAURIGENE ONCOLOGY LTD·Filed 2023·Application pending·0 cites
- 3852US10894786B2Substituted pyrazole derivatives as selective CDK12/13 inhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2019·Granted Jan 19, 2021·0 cites·25 claims
- 3952US10011599B2Compounds and compositions as inhibitors of MEKNOVARTIS AG·Filed 2017·Granted Jul 3, 2018·0 cites·5 claims
- 4051US2024254139A1Fused isoxazolyl compounds as kat6a inhibitorsAURIGENE ONCOLOGY LTD·Filed 2022·Application pending·0 cites
- 4150US10590118B2Bicyclic heterocyclic derivatives as bromodomain inhibitorsORION CORP·Filed 2018·Granted Mar 17, 2020·0 cites·9 claims
- 4250US2023322724A1Heterocyclic compounds as cbp/ep300 bromodomain inhibitorsAURIGENE ONCOLOGY LTD·Filed 2021·Application pending·0 cites
- 4350US2018141913A1Tetrasubstituted alkene compounds and their useEISAI R&D MAN CO LTD·Filed 2017·Application pending·0 cites
- 4450US2020255415A1Tetrasubstituted alkene compounds and their use for the treatment of breast cancerEISAI R&D MAN CO LTD·Filed 2017·Application pending·0 cites
- 4550US2023027075A1Sulfonamide compounds targeting cd73 and adenosine receptorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Application pending·0 cites
- 4649US10851065B2Tetrasubstituted alkene compounds and their useEISAI R&D MAN CO LTD·Filed 2017·Granted Dec 1, 2020·0 cites·20 claims
- 4749US2023212142A9Substituted 5-Cyclopropyl-1H-pyrazole-3-yl-amine Derivatives as Selective CDK12/13 InhibitorsAURIGENE DISCOVERY TECH LTD·Filed 2020·Application pending·0 cites
- 4848US9629836B2Compounds and compositions as inhibitors of MEKNOVARTIS AG·Filed 2015·Granted Apr 25, 2017·0 cites·5 claims
- 4940US10188627B2PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereofMITOBRIDGE INC·Filed 2015·Granted Jan 29, 2019·0 cites·28 claims
- 5038US2019337921A1Tetrasubstituted alkene compounds and their useEISAI R&D MAN CO LTD·Filed 2017·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Susanta Samajdar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →